[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356390-105":59,"doc-detail-356390-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","value-of-machine-learning-models-for-cell-free-dna-based-multi-cancer-early-detection-a-systematic-review-and-meta-analysis","Value of Machine Learning Models for Cell-Free DNA-Based Multi-Cancer Early Detection - A Systematic Review and Meta-Analysis","","Machine learning (ML)-based analysis of cell-free DNA (cfDNA) is explored as a multicancer early detection (MCED) strategy, addressing the inconsistency of diagnostic performance reported across studies. A systematic review and diagnostic accuracy meta-analysis was conducted using PubMed, Embase, Web of Science, and the Cochrane Library through February 2, 2025, including only independent validation/testing datasets. Pooled sensitivity and specificity were 0.78 and 0.96, with an AUC of 0.94; heterogeneity was linked to region, sample size, and biomarker type.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/value-of-machine-learning-models-for-cell-free-dna-based-multi-cancer-early-detection-a-systematic-review-and-meta-analysis/356390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/value-of-machine-learning-models-for-cell-free-dna-based-multi-cancer-early-detection-a-systematic-review-and-meta-analysis/356390.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"Why is independent validation important for ML-based cfDNA MCED assays?","Question",{"text":113,"@type":114},"The review excluded training datasets and included only independent validation/testing sets to improve relevance to real-world performance. It also highlights that diagnostic estimates vary widely when training or enriched cohorts are used.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What overall diagnostic performance did the meta-analysis find?",{"text":118,"@type":114},"Across 13 studies (23 independent datasets; 14,892 participants), pooled sensitivity was 0.78 and pooled specificity was 0.96. The summary AUC was 0.94 and the DOR was 76.6.",{"name":120,"@type":111,"acceptedAnswer":121},"What factors contributed most to between-study heterogeneity?",{"text":122,"@type":114},"Substantial heterogeneity (I2 > 90%) was observed, and subgroup analyses/meta-regression identified geographic region, sample size, and cfDNA biomarker type as major contributors.",{"name":124,"@type":111,"acceptedAnswer":125},"What does the conclusion suggest about clinical implementation?",{"text":126,"@type":114},"ML-based cfDNA assays showed consistently high specificity and moderate-to-high sensitivity, but performance was context dependent. The findings emphasize the need for large-scale prospective population-based validation before widespread clinical use.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},356390,1790720422,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":144,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Value of Machine Learning Models for Cell-Free DNA-Based Multi-Cancer Early Detection: A Systematic Review and Meta-Analysis  \nQiong Li, MS 1 , Hongde Liu, PhD 1,†, and Jinke Wang, PhD 1,†  \nTechnology in Cancer Research & Treatment  \nVolume 25: 1-19 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338261425328](DOI: 10.1177/15330338261425328)[ ](DOI: 10.1177/15330338261425328)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nAbstract  \nIntroduction: Machine learning (ML)–based analysis of cell-free DNA (cfDNA) has emerged as a promising strategy for multicancer early detection (MCED). However, reported diagnostic performance varies widely across studies, and many estimates are derived from training or enriched cohorts, limiting their relevance to independent validation and real-world settings. Methods: We conducted a systematic review and diagnostic accuracy meta-analysis of ML-based cfDNA assays for MCED. Four databases (PubMed, Embase, Web of Science, and the Cochrane Library) were searched from inception to February 2, 2025. Only independent validation or testing datasets were included; all training datasets were excluded. Pooled sensitivity, speciﬁcity, diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves were estimated using a bivariate random-effects model. Subgroup analyses and meta-regression were performed to explore sources of heterogeneity.  \nResults: Thirteen studies comprising 23 independent datasets and 14,892 participants were included. The pooled sensitivity was 0.78 (95% CI: 0.66-0.87), and the pooled speciﬁcity was 0.96 (95% CI: 0.90-0.98). The summary area under the curve (AUC) was 0.94, with a DOR of 76.6. Substantial between-study heterogeneity was observed (I2 >90%), with geographic region, sample size, and cfDNA biomarker type identiﬁed as major contributing factors.  \nConclusion: ML-based cfDNA assays demonstrate consistently high speciﬁcity and moderate-to-high sensitivity across independent validation datasets, supporting their potential role in multi-cancer early detection. However, diagnostic performance is highly context dependent and strongly inﬂuenced by study design, population characteristics, and analytical choices. These ﬁndings highlight the need for large-scale, prospective, population-based validation before widespread clinical implementation.  \nKeywords  \ncell-free DNA, machine learning, multi-cancer detection, early diagnosis, liquid biopsy, meta-analysis, methylation biomarkers, non-invasive screening  \nReceived: November 2, 2025; revised: December 30, 2025; accepted: February 2, 2026  \nIntroduction  \nEarly cancer detection is a cornerstone of effective cancer control, offering the opportunity to initiate treatment at a potentially curable stage, thereby signiﬁcantly improving patient prognosis and reducing cancer-related mortality.1 However, current population-based cancer screening strategies are highly fragmented. Most existing programs are developed for only a handful of malignancies, such as breast, cervical, colorectal, and lung cancers, and rely on distinct modalities, screening intervals, eligibility criteria, and clinical workﬂows.2,3 This siloed approach lacks scalability, consistency, and universal applicability across diverse populations and healthcare settings.  \n1 State Key Laboratory of Digital Medical Engineering, School of Biological  \nScience and Medical Engineering, Southeast University, Nanjing, China †These authors are co-corresponding authors.  \nCorresponding Authors:  \nHongde Liu, PhD, State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.  \nEmail: [liuhongde@seu.edu.cn](liuhongde@seu.edu.cn)  \nJinke Wang, PhD, State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical","cbCaiecQhSXaskCj","https://ap.wps.com/l/cbCaiecQhSXaskCj","pdf",2868405,14,"English","# Abstract\n# Introduction\n## Background and need for universal early detection\n## Limitations of current population screening\n# Methods\n# Results\n# Conclusion","[{\"question\":\"Why is independent validation important for ML-based cfDNA MCED assays?\",\"answer\":\"The review excluded training datasets and included only independent validation/testing sets to improve relevance to real-world performance. It also highlights that diagnostic estimates vary widely when training or enriched cohorts are used.\"},{\"question\":\"What overall diagnostic performance did the meta-analysis find?\",\"answer\":\"Across 13 studies (23 independent datasets; 14,892 participants), pooled sensitivity was 0.78 and pooled specificity was 0.96. The summary AUC was 0.94 and the DOR was 76.6.\"},{\"question\":\"What factors contributed most to between-study heterogeneity?\",\"answer\":\"Substantial heterogeneity (I2 \\u003e 90%) was observed, and subgroup analyses/meta-regression identified geographic region, sample size, and cfDNA biomarker type as major contributors.\"},{\"question\":\"What does the conclusion suggest about clinical implementation?\",\"answer\":\"ML-based cfDNA assays showed consistently high specificity and moderate-to-high sensitivity, but performance was context dependent. The findings emphasize the need for large-scale prospective population-based validation before widespread clinical use.\"}]","Value of Machine Learning Models for Cell-Free DNA-Based Multi-Cancer Early Detection - A Systematic Review and Meta-Analysis | PDF",1790125148,48,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08ed508bfbdcac7b0a5a80e41d8a6ae8.webp",983,1276,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfacfb97357a05a6fa7735f61e7d087c.webp",982,1275,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97ea90340c0fc3a1166e5451217bcb86.webp",981,1273,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4a29f91f9eec12fb8438b7395854839.webp",980,1272]